Bausch Health Companies Inc. (BHC)

Bausch Health Companies Inc. (BHC) is a healthcare company (drug manufacturers - specialty & generic) based in Canada. The share price is $8.33, down 1.07% on the day, which values the company at $3.12B. Price as of 17 Nov 2026, 17:30 UTC, from Yahoo Finance.

Key facts

Share price
$8.33−1.07% today
Market value
$3.12B
Forward P/E
1.9×
Funk Score
50/100
Against its own history
Well below its usual priceusual price $22.73
200-week average
$7.0318% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Bausch Health Companies Inc. in more detail

BHC trades at 1.9× next year's expected earnings, 0.3× sales. Measured against its own history, the price is 63% below what its usual multiples would imply ($22.73) — well below its usual price. It sits 18% above its 200-week average of $7.03.

Over the last five fiscal years Bausch Health Companies Inc. has compounded revenue 5.0% a year, free cash flow 4.2% a year. Its Funk Score is 50 out of 100 (financial strength 1.5, profitability 5.2, growth 4.8, value 8.3, each out of 10).

In its favour: Operating margin is expanding. Worth checking: Altman Z in the distress zone; Thin interest cover.

2 of the superinvestors tracked here hold BHC, including John Paulson (14.0% of the portfolio), Sarah Ketterer (0.0% of the portfolio).

Superinvestors holding BHC

2 of the investors tracked here report a position in their latest 13F filing.

Bausch Health Companies Inc. (BHC): questions and answers

What is BHC's PEG ratio?

Bausch Health Companies Inc.'s PEG ratio is 0.01 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Bausch Health Companies Inc.'s market cap?

Bausch Health Companies Inc. is valued at $3.12B at a share price of $8.33.

Is BHC overvalued or undervalued?

Against its own history, BHC is well below its usual price: the price is 63% below the $22.73 implied by the median multiples it has traded at (price / earnings, price / sales, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is BHC above its 200-week moving average?

Yes. BHC is 18.4% above its 200-week average of $7.03. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Bausch Health Companies Inc. growing?

Over the last five fiscal years Bausch Health Companies Inc.'s revenue grew 5.0% a year; over ten years revenue grew -0.2% a year.

Does BHC pay a dividend?

Bausch Health Companies Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Bausch Health Companies Inc. (BHC) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/BHC

Underlying data: Yahoo Finance; company filings with the SEC.